Results 301 to 310 of about 2,397,304 (343)

Theranostics with somatostatin receptor antagonists in SCLC: Correlation of ⁶⁸Ga-SSO120 PET with immunohistochemistry and survival. [PDF]

Theranostics
Mavroeidi IA, Romanowicz A, Haake T, Wienker J, Metzenmacher M, Darwiche K, Oezkan F, Bölükbas S, Stuschke M, Umutlu L, Opitz M, Nader M, Hamacher R, Siveke J, Winantea J, Fendler WP, Wiesweg M, Eberhardt WEE, Herrmann K, Theegarten D, Schuler M, Hautzel H, Kersting D.   +22 more
europepmc   +1 more source

Abnormal uptake related to the thyroid gland on somatostatin receptor-targeted PET imaging: reported prevalence and rate of thyroid malignancy and parathyroid adenomas. [PDF]

Endocr Connect
Sjöstedt SMS, Hahn CH, Rasmussen ÅK, Oturai PS, Cramon PK.   +4 more
europepmc   +1 more source

Somatostatin Receptor Subtype 4 Agonists for Potential Treatment of Alzheimer's Disease and Other Central Nervous System Disorders. [PDF]

ACS Med Chem Lett
Abdel-Magid AF.
europepmc   +1 more source

Somatostatin Receptor Subtype-2 Targeting System for Specific Delivery of Temozolomide. [PDF]

J Med Chem
AghaAmiri S, Ghosh SC, Hernandez Vargas S, Halperin DM, Azhdarinia A.   +4 more
europepmc   +1 more source

Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine.

J Clin Endocrinol Metab
Gadelha MR, Casagrande A, Strasburger CJ, Bidlingmaier M, Snyder PJ, Guitelman MA, Boguszewski CL, Buchfelder M, Shimon I, Raverot G, Tóth M, Mezősi E, Doknic M, Fan X, Clemmons D, Trainer PJ, Struthers RS, Krasner A, Biller BMK.   +18 more
europepmc   +1 more source

2025 ACVIM Forum Research Abstract Program

Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly